Enveric Biosciences

(NASDAQ) ENVB

Current Price$1.79

Market Cap$6.63M

Since IPO (2020)-100%

5 Year-100%

1 Year-88%

1 Month-43%

Enveric Biosciences Financials at a Glance

Market Cap

$6.63M

Revenue (TTM)

$0.00

Net Income (TTM)

-$8.22M

EPS (TTM)

-$27.35

P/E Ratio

-0.07

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Price

$1.79

Volume

181,734.127

Open

$1.99

Price

$1.79

Volume

181,734.127

Open

$1.99

Previous Close

$1.80

Daily Range

$1.71 - $2.01

52-Week Range

$1.71 - $17.64

Estimated Earnings Date

Aug 17, 2026

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Price

$1.79

Volume

181,734.127

Open

$1.99

Previous Close

$1.80

Daily Range

$1.71 - $2.01

52-Week Range

$1.71 - $17.64

Estimated Earnings Date

Aug 17, 2026

ENVB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Enveric Biosciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Joseph Tucker, PhD

Website

www.enveric.com

Headquarters

Naples, FL 34103, US

ENVB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-183%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-14.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.63M

Shares Outstanding

3.68M

Volume

181.73K

Avg. Volume

3.74M

Financials (TTM)

Gross Profit

-$200.86K

Operating Income

-$8.77M

EBITDA

-$8.57M

Operating Cash Flow

-$8.14M

Capital Expenditure

$0.00

Free Cash Flow

-$8.14M

Cash & ST Invst.

$4.68M

Total Debt

$0.00

Enveric Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$37.24K

+54.0%

Gross Margin

0.00%

N/A

Market Cap

$6.63M

N/A

Market Cap/Employee

$1.33M

N/A

Employees

N/A

Net Income

-$1.63M

+25.2%

EBITDA

-$1.60M

+24.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$4.91M

+14.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.49%

N/A

Return on Invested Capital

-1.62%

N/A

Free Cash Flow

-$2.26M

+5.6%

Operating Cash Flow

-$2.26M

+5.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INDPIndaptus Therapeutics, Inc.

INDPIndaptus Therapeutics, Inc.$3.66-22.95%

JSPRJasper Therapeutics, Inc.

JSPRJasper Therapeutics, Inc.$0.49+2.37%

SLRXSalarius Pharmaceuticals, Inc.

SLRXSalarius Pharmaceuticals, Inc.$0.84+29.23%

SLXNSilexion Therapeutics Ltd.

SLXNSilexion Therapeutics Ltd.$4.67-5.85%

ZVSAZyVersa Therapeutics, Inc.

ZVSAZyVersa Therapeutics, Inc.$0.20+17.65%

HEPAHepion Pharmaceuticals, Inc.

HEPAHepion Pharmaceuticals, Inc.$0.08+33.33%

SPRCSciSparc Ltd.

SPRCSciSparc Ltd.$11.44-0.87%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

MRVLMarvell Technology

MRVLMarvell Technology$263.47-0.17%

Questions About ENVB

What is the current price of Enveric Biosciences?

Enveric Biosciences is trading at $1.80 per share.

What is the 52-week range for Enveric Biosciences?

Over the past 52 weeks, Enveric Biosciences has traded between $1.71 and $17.64.

How much debt does Enveric Biosciences have?

As of the most recent reporting period, Enveric Biosciences reported total debt of $0.00.

How much cash does Enveric Biosciences have on hand?

Enveric Biosciences reported $4.91M in cash and cash equivalents in its most recent financial results.

What is Enveric Biosciences’s dividend yield?

Enveric Biosciences does not currently have a dividend yield.

Enveric Biosciences

Enveric Biosciences Financials at a Glance

ENVB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Enveric Biosciences

ENVB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Enveric Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ENVB

What is the current price of Enveric Biosciences?

What is the 52-week range for Enveric Biosciences?

How much debt does Enveric Biosciences have?

How much cash does Enveric Biosciences have on hand?

What is Enveric Biosciences’s dividend yield?

Premium Investing Services